MSM Malaysia Holdings Bhd (5202)
Kuala Lumpur Exchange · Malaysia · prices in MYR · close of 20 Oct 2026
Key indicators
| Last close | MYR 0.620 |
|---|---|
| 52-week range | 0.585 – 1.110 |
| Return, 1 month / 3 months | −2.4% / +2.5% |
| Return, 1 year / 3 years | −41.5% / −56.3% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 40.8% |
| Worst drawdown (1 year) | -45.9% |
| Average daily value traded | 0.32M MYR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MSM Malaysia Holdings Bhd is a Malaysian sugar refiner. It processes raw sugar into refined white sugar and other sugar products, which it supplies to food and beverage manufacturers, wholesalers, retailers and household customers in Malaysia and export markets. The company is based in Malaysia and is part of the FGV Holdings plantation group. Its refined sugar is sold under the Gula Prai brand, and it also offers related products such as molasses and liquid sugar to industrial users.
MSM Malaysia Holdings Bhd trades under the code 5202 on the Kuala Lumpur Exchange in Malaysia, with its price quoted in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MSM Malaysia Holdings Bhd (5202) trades on the Kuala Lumpur Exchange in Malaysia. It last closed at MYR 0.620 on 20 October 2026.
Its price-based Market X-Ray is 34 out of 100 (a weak price profile), ranking 808 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 41.5% and over the last three months it rose 2.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Kuala Lumpur Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 14 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -18.8% | ||
| From 52-week high | -43.1% | ||
| Momentum | 32 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 2.5% | ||
| 6-month return | -25.3% | ||
| 12-month return, skipping the last month | -40.1% | ||
| Stability (higher is calmer) | 37 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.9% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.32M MYR | ||
| Zero-volume days | 5.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −1.6% |
|---|---|
| 1 month | −2.4% |
| 3 months | +2.5% |
| 6 months | −25.3% |
| 1 year | −41.5% |
| 3 years | −56.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 0.656 / 0.763 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.021 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Mar 2022 | MYR 0.0300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Kuala Lumpur Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.